The risk of non-selective NSAIDs and selective cyclooxygenase-2 inhibitors is not modified by use of evidence-based pharmacotherapy in chronic heart failure

Gunnar H. Gislason, Jeppe N. Rasmussen, Steen Z. Abildstrom, Soren Rasmussen, Tina K. Schramm, Fredrik Folke, Morten L. Hansen, Lars Kober, Mette Madsen, Christian Torp-Pedersen

Research output: Contribution to journalJournal articleResearchpeer-review

Original languageEnglish
JournalCirculation
Volume116
Issue number16
Pages (from-to)736-736
ISSN0009-7322
Publication statusPublished - 16 Oct 2007

Cite this